These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27090347)

  • 1. Novel role of midodrine in pulmonary hypertension in liver transplant candidates.
    Rajaram P; Spivey J; Fisher M
    Liver Transpl; 2016 Jul; 22(7):1034-6. PubMed ID: 27090347
    [No Abstract]   [Full Text] [Related]  

  • 2. MELD exception for liver transplantation in portopulmonary hypertension: current implementation and future considerations.
    Porres-Aguilar M; Bartolome SD; Duarte-Rojo A
    Ann Hepatol; 2014; 13(6):719-21. PubMed ID: 25332257
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac and pulmonary issues in LT assessment candidates.
    McAvoy NC; Hayes PC
    Clin Liver Dis; 2014 Aug; 18(3):529-41. PubMed ID: 25017074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
    Krowka MJ; Wiesner RH; Heimbach JK
    J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portopulmonary hypertension in liver transplant candidates.
    Bozbas SS; Bozbas H
    World J Gastroenterol; 2016 Feb; 22(6):2024-9. PubMed ID: 26877607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portopulmonary hypertension and the liver transplant candidate.
    Kuo PC; Plotkin JS; Gaine S; Schroeder RA; Rustgi VK; Rubin LJ; Johnson LB
    Transplantation; 1999 Apr; 67(8):1087-93. PubMed ID: 10232556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
    Singh V; Singh A; Singh B; Vijayvergiya R; Sharma N; Ghai A; Bhalla A
    Am J Gastroenterol; 2013 Apr; 108(4):560-7. PubMed ID: 23419385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP9/10 in Pulmonary Vascular Complications of Liver Disease.
    Rochon ER; Krowka MJ; Bartolome S; Heresi GA; Bull T; Roberts K; Hemnes A; Forde KA; Krok KL; Patel M; Lin G; McNeil M; Al-Naamani N; Roman BL; Yu PB; Fallon MB; Gladwin MT; Kawut SM
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1575-1578. PubMed ID: 32083953
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of midodrine in protein-losing enteropathy.
    Weingarten AJ; Menachem JN; Smith CA; Frischhertz BP; Book WM
    J Heart Lung Transplant; 2019 Jul; 38(7):784-787. PubMed ID: 31031017
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
    Sağ S; Yeşilbursa D; Güllülü S
    Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
    Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
    Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
    Ali A; Farid S; Amin M; Kassem M; Al-Garem N
    Hepatogastroenterology; 2014 Oct; 61(135):1915-24. PubMed ID: 25713888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.
    Raevens S; Boret M; De Pauw M; Fallon MB; Van Vlierberghe H
    Hepatology; 2021 Sep; 74(3):1674-1686. PubMed ID: 33636019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in the treatment of portopulmonary hypertension?
    DuBrock HM; Channick RN; Krowka MJ
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):983-92. PubMed ID: 25882070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cardiac manifestations in pediatric liver transplant candidates.
    Madan N; Arnon R; Arnon R
    Pediatr Transplant; 2012 Jun; 16(4):318-28. PubMed ID: 22420530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension associated with portal hypertension. Apropos of 2 cases].
    Mirode A; Tribouilloy C; Boulanger J; Adam MC; Trojette F; Lesbre JP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1647-50. PubMed ID: 8746001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligating coronary vein varices: An effective treatment of "coronary vein steal" to increase portal flow in liver transplantation.
    Gupta A; Klintmalm GB; Kim PT
    Liver Transpl; 2016 Jul; 22(7):1037-9. PubMed ID: 27028766
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.
    Uchiyama H; Soejima Y; Taketomi A; Yoshizumi T; Harada N; Ijichi H; Yonemura Y; Maehara Y
    Liver Transpl; 2006 Mar; 12(3):481-4. PubMed ID: 16498645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in liver transplant.
    Ayoub T
    Curr Opin Organ Transplant; 2011 Jun; 16(3):331-7. PubMed ID: 21519260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes.
    Rajoriya N; Tripathi D; Leithead JA; Gunson BK; Lord S; Ferguson JW; Hirschfield GM
    World J Gastroenterol; 2016 Dec; 22(45):9966-9973. PubMed ID: 28018103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.